NWBO

Northwest Biotherapeutics, Inc. Press Releases

$5.26
*  
0.19
3.49%
Get NWBO Alerts
*Delayed - data as of Sep. 22, 2014 13:24 ET  -  Find a broker to begin trading NWBO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NWBO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NW BIO'S CANCER VACCINE IS THE FIRST DRUG TO BE DESIGNATED BY UK AUTHORITIES AS A "PROMISING INNOVATIVE MEDICINE" (PIM)
9/16/2014 8:00:00 AM - PR Newswire

NW BIO CEO TO PRESENT AT SMi's 3rd ANNUAL CANCER VACCINES CONFERENCE IN LONDON
9/15/2014 8:00:00 AM - PR Newswire

NW BIO TO PRESENT UPDATES AT RODMAN RENSHAW 16TH ANNUAL GLOBAL INVESTMENT CONFERENCE
9/8/2014 8:15:00 AM - PR Newswire

NW BIO COMPLETES THE CLOSING OF ITS $17.5 MILLION CONVERTIBLE NOTE OFFERING
8/19/2014 2:44:00 PM - PR Newswire

NW BIO ANNOUNCES PRICING OF $17.5 MILLION OFFERING OF CONVERTIBLE NOTES
8/14/2014 11:47:00 AM - PR Newswire

NW BIO CORRECTS ONGOING FALSE CLAIMS BY FEUERSTEIN ABOUT PHASE III TRIAL OF DCVAX®-L, AND INTERIM ANALYSIS
8/13/2014 9:26:00 AM - PR Newswire

NW BIO PROVIDES UPDATE ABOUT PHASE III DCVAX®-L TRIAL FOR GBM AND "INFORMATION ARM" COMPASSIONATE USE PATIENTS
8/11/2014 8:15:00 AM - PR Newswire

NW BIO OBTAINS APPROVALS FOR ENHANCEMENTS OF PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER
8/11/2014 8:15:00 AM - PR Newswire

Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
8/11/2014 8:00:00 AM - Business Wire

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Northwest Biotherapeutics, Inc. Stockholders
7/23/2014 7:13:00 PM - Business Wire

NW BIO ANNOUNCES COMPLETION OF DCVAX®-DIRECT PHASE I TRIAL RECRUITMENT
7/16/2014 8:15:00 AM - PR Newswire

INVESTOR ALERT – Andrews & Springer LLC Is Investigating Northwest Biotherapeutics, Inc. For Possible Violations of Securities Laws - NWBO
7/9/2014 8:00:00 AM - Business Wire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Northwest Biotherapeutics, Inc. - NWBO
7/7/2014 6:31:00 PM - PR Newswire

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Northwest Biotherapeutics, Inc. (NWBO) To Contact The Firm
7/4/2014 1:17:00 PM - PR Newswire

Robbins Arroyo LLP Is Investigating the Officers and Directors of Northwest Biotherapeutics, Inc. on Behalf of Shareholders
7/1/2014 1:33:00 PM - PR Newswire

Biotech Stocks on the Move -- Research on CTI BioPharma, BioMarin Pharma, Vertex Pharma, and Northwest Biotherapeutics
6/27/2014 7:00:00 AM - PR Newswire